DEA Intends to Restrict Imports and Exports of Three Synthetic Cannabinoids
The Drug Enforcement Administration has announced its intent to temporarily include three synthetic cannabinoids into Schedule I of the Controlled Substances Act. Synthetic cannabinoids are chemicals synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol, the main psychoactive ingredient in marijuana. The specific substances targeted under this action are:
- N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (common name AB-CHMINACA);
- N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (common name AB-PINACA); and
- [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (common name THJ-2201).
The DEA notes that this action is based on a finding that the placement of these synthetic cannabinoids into Schedule I is necessary to avoid an imminent hazard to the public safety. Any final order, which the DEA states will be issued as soon as possible after the expiration of a 30-day layover period, will impose the administrative, civil and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research and conduct of instructional activities of these synthetic cannabinoids.